Michael Grey
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Grey
Michael Grey is recorded as CEO at Mirum Pharmaceuticals, Inc. (MIRM). The proxy statement of Mirum Pharmaceuticals, Inc. reports total compensation of $5,662,396 for Michael Grey in fiscal 2019, including a base salary of $300,000. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Mirum Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher Peetz CEO
- Eric Bjerkholt CFO
- Peter Radovich COO
- Lon Cardon, Ph.D., FMedSci Board Member
- Saira Ramasastry Board Member
- Timothy Walbert Board Member
- To approve Board Member
- William Fairey Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Mirum Pharmaceuticals, Inc. (MIRM) | Former Executive Chairman and Chief Executive Officer | $300,000 | $5,662,396 |
| 2018 | Mirum Pharmaceuticals, Inc. (MIRM) | Former Executive Chairman and Chief Executive Officer | $25,000 | $25,000 |
Recent activity
No call appearances or filed executive changes recorded yet.